Gen-Probe Adds European Reach Through $132 Million Tepnel Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Gen-Probe will double its European sales force and expand its existing molecular diagnostics portfolio through the $132.2 million purchase of UK-based Tepnel Life Sciences
You may also be interested in...
Gen-Probe Adds Influenza Tests To Diagnostics Portfolio With Prodesse Buy
Nucleic acid test maker Gen-Probe will gain a growing pipeline of molecular diagnostics for infectious diseases and add flu tests for the first time through its purchase of privately-held Prodesse, announced Oct. 6
Gen-Probe Adds Influenza Tests To Diagnostics Portfolio With Prodesse Buy
Nucleic acid test maker Gen-Probe will gain a growing pipeline of molecular diagnostics for infectious diseases and add flu tests for the first time through its purchase of privately-held Prodesse, announced Oct. 6
Innogenetics Weighs Solvay’s Sweetened Takeover Offer Trumping Gen-Probe
Gen-Probe says it will not increase its offer for Belgian molecular diagnostics firm Innogenetics now that drug maker Solvay has submitted a higher bid, worth $316 million for all of Innogenetics' outstanding shares